These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21281749

  • 21. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
    [Abstract] [Full Text] [Related]

  • 22. Relevance of parathyroid hormone (PTH), vitamin 25(OH)D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases.
    Zhang M, Li Y, Ma Q, Mao W, Gao Y, Liu Y, Liang B.
    Clin Exp Obstet Gynecol; 2015 Nov; 42(2):129-32. PubMed ID: 26054103
    [Abstract] [Full Text] [Related]

  • 23. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [Abstract] [Full Text] [Related]

  • 24. Relationship between fetuin-A, bone turnover and inflammatory markers concentrations in serum of maintenance hemodialyzed patients.
    Fedak D, Kuźniewski M, Dumnicka P, Kapusta M, Chmiel G, Solnica B, Sułowicz W.
    Przegl Lek; 2016 Aug; 73(11):799-804. PubMed ID: 29693340
    [Abstract] [Full Text] [Related]

  • 25. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S, Sands RL, Gillespie BW, Gnanasekaran G, Zannad F, Sengstock D, Finkelstein F, Kiser M, Eisele G, Hinderliter AL, Levin NW, Cattan V, Saran R, Rajagopalan S.
    Nephrol Dial Transplant; 2011 Sep; 26(9):2891-8. PubMed ID: 21562144
    [Abstract] [Full Text] [Related]

  • 26. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK.
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [Abstract] [Full Text] [Related]

  • 27. Effect of serum fibroblast growth factor-23, matrix Gla protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients.
    Wu Q, Xiao DM, Fan WF, Ye XW, Niu JY, Gu Y.
    Ther Apher Dial; 2014 Oct; 18(5):427-33. PubMed ID: 25196492
    [Abstract] [Full Text] [Related]

  • 28. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
    Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA, European Uremic Toxin (EUTox) Work Group.
    Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM.
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [Abstract] [Full Text] [Related]

  • 30. Assessment of Bone Turnover Biomarkers in Lead-Battery Workers with Long-Term Exposure to Lead.
    Kalahasthi R, Barman T, Bagepally BS.
    Int J Occup Environ Med; 2020 Jul; 11(3):140-147. PubMed ID: 32683426
    [Abstract] [Full Text] [Related]

  • 31. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
    Haarhaus M, Fernström A, Qureshi AR, Magnusson P.
    Nutrients; 2021 Dec 09; 13(12):. PubMed ID: 34959954
    [Abstract] [Full Text] [Related]

  • 32. Association between bone mineral metabolism and vascular calcification in end-stage renal disease.
    Aaltonen L, Koivuviita N, Seppänen M, Kröger H, Tong X, Löyttyniemi E, Metsärinne K.
    BMC Nephrol; 2022 Jan 03; 23(1):12. PubMed ID: 34979983
    [Abstract] [Full Text] [Related]

  • 33. Changes in bone mass and bone turnover following ankle fracture.
    Ingle BM, Hay SM, Bottjer HM, Eastell R.
    Osteoporos Int; 1999 Jan 03; 10(5):408-15. PubMed ID: 10591839
    [Abstract] [Full Text] [Related]

  • 34. News on biomarkers in CKD-MBD.
    Mazzaferro S, Tartaglione L, Rotondi S, Bover J, Goldsmith D, Pasquali M.
    Semin Nephrol; 2014 Nov 03; 34(6):598-611. PubMed ID: 25498379
    [Abstract] [Full Text] [Related]

  • 35. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
    Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S, Turgan C.
    Artif Organs; 2009 Oct 03; 33(10):844-54. PubMed ID: 19681840
    [Abstract] [Full Text] [Related]

  • 36. Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients.
    Porazko T, Kuźniar J, Kusztal M, Kuźniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.
    Nephron Clin Pract; 2009 Oct 03; 113(2):c81-7. PubMed ID: 19602903
    [Abstract] [Full Text] [Related]

  • 37. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
    Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtimäki T, Schmidt-Gayk H, Uusi-Rasi K, Heinonen A, Kannus P, Sievänen H, Vuori I, Väänänen HK, Halleen JM.
    J Bone Miner Res; 2005 Oct 03; 20(10):1804-12. PubMed ID: 16355501
    [Abstract] [Full Text] [Related]

  • 38. Bone metabolism and arterial stiffness after renal transplantation.
    Cseprekál O, Kis E, Dégi AA, Kerti A, Szabó AJ, Reusz GS.
    Kidney Blood Press Res; 2014 Oct 03; 39(6):507-15. PubMed ID: 25531154
    [Abstract] [Full Text] [Related]

  • 39. Vascular calcification in chronic kidney disease.
    Jono S, Shioi A, Ikari Y, Nishizawa Y.
    J Bone Miner Metab; 2006 Oct 03; 24(2):176-81. PubMed ID: 16502129
    [Abstract] [Full Text] [Related]

  • 40. [Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker].
    Okuno S, Inaba M.
    Clin Calcium; 2009 Aug 03; 19(8):1084-91. PubMed ID: 19638691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.